Mahindra Lifespace Developers Full Year 2025 Earnings: Misses Expectations

April 27, 2025

Mahindra Lifespace Developers (NSE:MAHLIFE) Full Year 2025 Results

Key Financial Results

Revenue: ₹4.64b (up 119% from FY 2024).
Net income: ₹612.9m (down 38% from FY 2024).
Profit margin: 13% (down from 46% in FY 2024). The decrease in margin was driven by higher expenses.
EPS: ₹3.95 (down from ₹6.34 in FY 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

earnings-and-revenue-growth — NSEI:MAHLIFE Earnings and Revenue Growth April 27th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Mahindra Lifespace Developers Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 40%. Earnings per share (EPS) also missed analyst estimates by 51%.

Looking ahead, revenue is forecast to grow 40% p.a. on average during the next 2 years, compared to a 22% growth forecast for the Real Estate industry in India.

Performance of the Indian Real Estate industry.

The company's shares are up 6.1% from a week ago.

Risk Analysis

We should say that we've discovered 4 warning signs for Mahindra Lifespace Developers (2 are concerning!) that you should be aware of before investing here.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.